References
1 Khanna R, Verma SK. Pediatric hepatocellular carcinoma. World J
Gastroenterol 2018;24:3980-3999.
2 Kulik L, El-Serag HB. Epidemiology and management of hepatocellular
carcinoma. Gastroenterology 2019;156:477-491.
3 Kudo M, Fin RS, Qin S, Han KH, Ikeda K, Piscaglia F, Baron Ari, Park
JW, Han G, Jassem J, Blanc J-F, Vogel A, Komov D, Evans TR-J, Lopez C,
Dutcus C, Guo M, Saito K, Kraljevic S, Tamai T, Ren M, Cheng
A-L. Lenvatinib versus sorafenib in first-line treatment of
patients with unresectable hepatocellular carcinoma: a randomised phase
3 non-inferiority trial. Lancet 2018;391:1163-1173.
4 Prokurat A, Kluge P, Kosciesza A, Perek D, Kappeler A, Zimmermann A.
Transitional liver cell tumor (TLCT) in older children and adolescents:
A novel group of aggressive hepatic tumors expressing beta-catenin. Med
Pediatr Oncol 2002;39:510-518.
5 H N Ozcan, B Oguz, T Salim, B Talim, M Halilogu. A rare malignant
hepatic tumor of childhood: Transisional liver cell tumor revisited.
JBR-BTR 2015;98:79-81.
6 F Sasaki, T Matsunaga, M Iwafuchi, Y Hayashi, H Ohkawa, M Ohira, T
Okamatsu, T Sugito, Y Tsuchida, A Toyosaka, N Nagahara, H Nishihira, Y
Hata, J Uvhino, K Misugi, N Ohnuma, (Japanese Study Group for Pediatric
Liver Tumor). Outcome of hepatoblastoma treated with the JPLT-1
(Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report
from the Japanese Study Group for Pediatric Liver Tumor. J Pediatr Surg
2002;37:851-856.
7 G Perilongo, E shafford, R Maibach, D Aronson, L Brugieres, P Brock, M
Childs, P Czauderna, G MacKinlay, J Pritchard, R Rondelli, M Scopinaro,
C staalman, J Plaschkes, International Society of Pediatric
Oncology-SIOPEL2. Risk-adapted treatment for childhood hepatoblastoma
final report of the second study of the International Society of
Paediatric Oncology—SIOPEL 2. Eur J Cancer 2004;40:411-421.
8 P F Ehrich, M L Greenberg, R M Filler. Improved long-term survival
with preoperative chemotherapy for hepatoblastoma. J Pediatr Surg
1997;32:999-1002.
9 Marcio H Malogolowkin, Howard M Katzenstein, Rebecka L Meyers, Mark
Krailo, Jon M Rowland, Joel Haas, Milton J Finegold. Complete surgical
resection is curative for children with hepatoblastoma with pure fetal
histology: A report from the Children’s Oncology Group. J Clin Oncol
2011;29:3301-3306.
10 Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Liu-Mares W,
Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ,
Haas JE, Sensel MG, Castleberry RP, Browman LC. Hepatocellular carcinoma
in children and adolescents: results from the Pediatric Oncology Group
and the Children’s Cancer Group Intergroup Study. J Clin Oncol
2002;20:2789-2797.
11 Haines K, Sarabia SF, Alvarez KR, Tomlinson G, Vasudevan SA, Heczey
AA, Roy A, Finegold MJ, Parsons DW, Plon SE, Lopez-Terrada D.
Characterization of pediatric hepatocellular carcinoma reveals genomic
heterogeneity and diverse signaling pathway activation. 2019. Pediatr
Blood Cancer 2019;66:doi: 10.1002/pbc.27745.
12 Yamaoka H, Ohtsu K, Sueda T, Yokoyama T, Hiyama E. Diagnostic and
prognostic impact of beta-catenin alterations in pediatric liver tumors.
Oncol Rep 2006;15:551-556.
13 Jayasinghe RG, Cao S, Gao Q, Wendl MC, Vo NS, Reynolds SM, Zhao Y,
Climente-González H, Chai S, Wang F, Varghese R, Huang M, Liang WW,
Wyczalkowski MA, Sengupta S, Li Z, Payne SH, Fenyȍ D, Miner JH, Walter
MJ, Cancer Genome Atlas Reseach Network; Vincent B, Eyras E, Chen K,
Shmulevich I, Chen F, Ding L. Systematic analysis of
splice-site-creating mutations in cancer. 2018 Cell Rep
2018;23:270-281.e3.